Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alogabat - Genentech

Next Previous
Drug Profile

Alogabat - Genentech

Alternative Names: GABA-Aa5 PAM; RG-7816; RG7816 alogabat; RO-7017773

Latest Information Update: 28 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche
  • Class Behavioural disorder therapies; Small molecules
  • Mechanism of Action GABA A alpha 5 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Pervasive child development disorders

Most Recent Events

  • 17 May 2024 Hoffmann-La Roche completes a phase II trial in Pervasive child development disorders (In adolescents, In adults) in USA, Canada, Italy and Spain (PO) (NCT04299464)
  • 09 May 2024 Roche intends to submit regulatory application for Pervasive child development disorders, in or after 2027 (Roche pipeline, May 2024)
  • 29 Nov 2022 Hoffmann-La Roche plans a phase II trial for Angelman syndrome (In children, In adolescents) in January 2023 (PO) (NCT05630066)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top